BDSX · Biodesix Inc
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Sep 15, 2025; bars on opposite sides are not compared.
The closing range begins at the captured split on Sep 15, 2025.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BDSX
this stock
Biodesix Inc
|
$277.97M | +287.4% | +24.1% | — | 1.4% |
|
TMO
Thermo Fisher Scientific Inc.
|
$230.05B | +6.5% | +14.5% | 33.5 | 1.3% |
|
DHR
Danaher Corp /De/
|
$147.09B | -6.7% | +8.5% | 37.1 | 1.2% |
|
NTRA
Natera, Inc.
|
$47.03B | +40.5% | -2.8% | — | 3.0% |
|
IDXX
Idexx Laboratories Inc /De
|
$43.72B | -17.7% | +10.4% | 39.0 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Sep 15, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BDSX | +3.8% | +19.6% | +40.7% | +24.3% | +287.4% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | +3.3% | +18.4% | +27.5% | +21.6% | +275.0% |